Clinical Trial

Specimens for Lung Cancer Panel Design

Recruiting
View on ClinicalTrials.gov →
Summary
This is an observational study designed to determine the optimal combination of biomarkers and clinical data for the early detection, confirmation, and better treatment of lung cancer including minimizing recurrence.
Trial Details
NCT Number NCT07401797
Lead Sponsor Maverix Medical
Conditions Lung Nodules
Enrollment 2,000 participants
Start Date 2024-08-07
Primary Completion 2029-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-10